Cervical Interbody Fusion Cage System
- UID
- IMP/MD/2018/000363_19a7743fa88cc346f86767d3f2113cc3_a998758410b75c130e5fa58b2f2fb952
- Device class
- Class C
- Brand name
- LnK, PathLoc-L
- License holder
- L&K Biomed India Private Limited
- Approving authority
- CDSCO
- Product information
- LnK/CastleLoc‐C Cervical Interbody Fusion Cage System is indicated for use in skeletally mature patients with degenerative disc disease (LnK, PathLoc-L) of the cervical spine with accompanying radicular symptoms at one disc level. DDD is defined as disogenic pain with degeneration of the disc confirmed by patient history and radiographic studies. LnK/CastleLoc‐C Cervical Interbody Fusion Cage System is used to facilitate Interbody Fusion in the cervical spine at the C3 to C7 disc levels using autograft bone. LnK/CastleLoc‐C Cervical Interbody Fusion Cage System is to be used with supplemental fixation. Patients should have at least six (LnK, PathLoc-L) weeks of non‐operative treatment prior to treatment with an intervertebral cage
Cervical Interbody Fusion Cage System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000363_19a7743fa88cc346f86767d3f2113cc3_a998758410b75c130e5fa58b2f2fb952. This device is marketed under the brand name LnK, PathLoc-L. The license holder is L&K Biomed India Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.